The effect of clothes on blood pressure measurement.

OBJECTIVE: To determine the effect of clothes on blood pressure measurement. METHODS: One group pretest-posttest design was used in this study. The study consisted of 162 undergraduate students studying nursing and physiotherapy at a university in Ankara, Turkey. Blood pressure was measured over the sleeve and below a rolled-up sleeve with a mercury-filled column sphygmomanometer. All blood pressure measurements were performed on the right arm during morning hours by the same nurse. Each participant's height, weight and clothing thickness were measured. RESULTS: The mean age of the participants was 20.71. The median systolic blood pressure values were 110.07 mmHg over the sleeve and 110.37 mmHg below the rolled-up sleeve. There were no statistically significant differences between measurements taken over the sleeve and below a rolled-up sleeve (p=0.222). The median diastolic blood pressure values were 69.56 mmHg over the sleeve and 69.59 mmHg below the rolled-up sleeve. There were no statistically significant differences between measurements taken over the sleeve and below a rolled-up sleeve (p=0.572). CONCLUSION: It was found that clothes have no statistically significant effect on systolic/diastolic blood pressure measurements. Measuring blood pressure over a sleeve may save time.

Future Prospects in Parkinson's Disease Diagnosis and Treatment.

Parkinson's disease (PD) is a neurodegenerative disease with a rapidly increasing incidence and prevalence. Although it affects more than 6 million people worldwide, it is predicted to be doubled by 2040. Current criteria used in the diagnosis of PD include the presence of bradykinesia as well as the presence of rest tremor and/or rigidity, but the clinic is multifaceted and includes many non-motor symptoms. Non-motor symptoms may occur in the prodromal period, years before clinically evident Parkinson's disease. During this period, diagnosing the disease will likely be even more important when disease-modifying treatments are available. Currently, there is no single biomarker that can be used in the diagnosis of PD and no disease-modifying treatment is available. Identification of biomarkers in early diagnosis will enable the most effective use of disease-modifying therapies and will shed light on possible underlying pathologies, studies in this area have gained momentum in recent years. Molecular imaging methods, genetic studies, salivary gland and skin biopsies, metabolomics, lysosomal pathway are some of them. In this article, besides the current diagnosis and treatment methods of the disease, biomarkers and treatments that are expected to be better understood in the near future will be mentioned.